On January 17, 2025, another meeting of the ENT Society of Astana was held in the city of Astana with the support of Chiesi Farmaceutici S.p.A and LLP VK "Hearing Rehabilitation Center." The event brought together leading otorhinolaryngologists, audiologists, and researchers to discuss advancements in diagnosing and managing hearing impairments associated with genetic disorders.

At this meeting, a report was presented on 'Alpha-Mannosidosis and Hearing Loss.' The presentation highlighted the importance of early genetic screening for rare metabolic disorders, their impact on auditory function, and the latest therapeutic approaches to managing hearing loss in affected patients.

The discussion sparked great interest among specialists, emphasizing the need for interdisciplinary collaboration in the early detection and treatment of genetic hearing impairments. The meeting concluded with an exchange of experiences and ideas on integrating genetic diagnostics into routine ENT practice to enhance patient outcomes.

#rarediseasecompanykazakhstan #businessdevelopmentinkazakhstan #PharmandAccess #CentralAsia #SareptaTherapeutics #orphandiseasepatientsinKazakhstan #orphanpharmaceuticalcompanyinKazakhstan #rarediseasepatientsinCentralAsia #orphanpharmacompany